- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DexCom Inc (DXCM)
Track today's live DexCom (DXCM) share price, performance and key data on this page with our current NASDAQ:DXCM stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the DexCom share price on the NASDAQ exchange. Use the dropdown to switch exchange for the DXCM share price, head to our technical summary section, which provides analysis on DexCom share price buy/sell indicators using real-time data (or discuss the DexCom (DXCM) stock price today with other investors in the DexCom NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:DXCM share price (ISIN: US2521311074) to enhance your trading decisions with our free investment tools and resources.
What Is the DexCom Inc Share Price Today?
The DexCom share price today is 83.45.
What Is the Stock Symbol for DexCom Inc
The stock symbol (or 'ticker') for DexCom Inc is "DXCM."
What Stock Exchange Does DexCom Inc Trade On?
DexCom Inc is listed and trades on the NASDAQ stock exchange.
Is DexCom Inc a Good Stock to Buy?
Determining whether DexCom (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:DXCM share price (ISIN: US2521311074) to enhance your trading decisions with our free investment tools and resources.
What Is the DexCom Inc Share Price Today?
The DexCom share price today is 83.45.
What Is the Stock Symbol for DexCom Inc
The stock symbol (or 'ticker') for DexCom Inc is "DXCM."
What Stock Exchange Does DexCom Inc Trade On?
DexCom Inc is listed and trades on the NASDAQ stock exchange.
Is DexCom Inc a Good Stock to Buy?
Determining whether DexCom (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
79.50
84.70
52 wk Range
54.11
84.70
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
79.5084.70
52 wk Range
54.1184.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DXCM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
86.16
Upside
+3.25%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Management has been aggressively buying back shares
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
25 Buy
3 Hold
0 Sell
Ratings:
28 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 86.16
(+3.25% Upside)
DexCom Inc SWOT Analysis
Diabetes Tech Leade | DexCom dominates the continuous glucose monitoring market with strong sales growth and record new patient starts, despite facing recent margin pressures from supply chain challenges. |
Growth Catalysts | Expansion into the Type 2 diabetes market and the upcoming G7 15-day sensor launch present significant opportunities, with 6 million new covered lives expected by year-end 2025. |
Financial Headwinds | Despite robust sales of $1.04 billion in Q1 2025, DexCom faces margin challenges from quality initiatives and supply issues, prompting revised forecasts for 2026. |
Analyst Outlook | Price targets range from $80 to $102, averaging $91.25, reflecting mixed sentiment as DexCom balances market leadership against competitive threats from Abbott and potential regulatory hurdles. |
DexCom Inc Earnings Call Summary for Q2/2026
- Dexcom Q2 profit hit $0.70/share on $1.31B revenue, beating estimates of $0.61/share and $1.29B; shares surged 8.64% after-hours to $80.98.
- Revenue rose 13% YoY with U.S. sales up 11% to $933M and international up 19% to $375M; gross margin expanded to 64.1% from 60.1% prior year.
- Company raised FY2026 revenue guidance to $5.18B-$5.25B (11-13% growth) and lifted margin targets to 64% gross, 23.5-24% operating, 31.5-32% EBITDA.
- G7 15-day system on track to convert nearly half of U.S. customers by year-end; CONNECT trial showed 1.6% A1C improvement supporting broader adoption.
- Free cash flow exceeded $600M in H1 2026, more than double prior year; company faces $15M FX headwinds and Ireland factory startup costs in H2.
Last Updated: 30/07/2026, 22:48
Read Full TranscriptEarnings
Latest Release
30/07/2026
EPS / Forecast
0.70 / 0.61
Revenue / Forecast
1.31B / 1.29B
Compare DXCM to Peers and Sector
Metrics to compare | DXCM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDXCMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.1x | 20.8x | −0.3x | |
PEG Ratio | 0.41 | −0.76 | 0.00 | |
Price/Book | 10.7x | 2.4x | 2.6x | |
Price / LTM Sales | 5.7x | 2.7x | 3.0x | |
Upside (Analyst Target) | 7.8% | 43.3% | 56.6% | |
Fair Value Upside | Unlock | −3.3% | 10.2% | Unlock |
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the DexCom (NASDAQ: DXCM) Share Price Today?
The DexCom stock price today is 83.45 USD.
What Stock Exchange Does DexCom (DXCM) Trade On?
DexCom is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for DexCom?
The stock symbol (also called a 'ticker') for DexCom is "DXCM."
What Is the Current DexCom Market Capitalisation?
As of today, DexCom (NASDAQ: DXCM) market cap is 28.13B USD.
What Is DexCom's (DXCM) Earnings Per Share (TTM)?
The DexCom EPS is currently 2.34 (Trailing Twelve Months).
When Is the Next DexCom Earnings Date?
DexCom's next earnings report will be released on 22/10/2026.
Is DXCM a Buy or Sell From a Technical Analyst Perspective?
Based on today's DexCom moving averages and other technical indicators, the daily buy/sell signal for DXCM stock is Strong Buy.
How Many Times Has DexCom Stock Split?
DexCom has split 1 times. (See the DXCM stock split history page for full effective split date and price information.)
How Many Employees Does DexCom Have?
DexCom has 11050 employees, based on their latest Companies House report.
What is the current trading status of DexCom (NASDAQ: DXCM)?
As of 31/07/2026, DexCom (DXCM) is trading at a share price of 83.45 USD, with a previous close of 74.54 USD. The stock has fluctuated within a day range of 79.50 USD to 84.70 USD, while its 52-week range spans from 54.11 USD to 84.70 USD.
What Is DexCom (DXCM) Price Target According to Analysts?
The average 12-month price target for DexCom is 86.16 USD, with a high estimate of 112 USD and a low estimate of 65 USD. 25 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +3.25% Upside potential.
What Is the DXCM Premarket Price?
DXCM's last pre-market stock price is 79.31 USD. The pre-market share volume is 47,100.00, and the stock has decreased by 4.77, or 6.40%.
What Is the DXCM After Hours Price?
DXCM's last after hours stock price is 82.45 USD, the stock has decreased by -1.00, or -1.19%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.